Pyroptosis in cancer nanotherapy: Molecular mechanisms and advanced nanosystems (Review)
International Journal of Oncology · 30.10.2026 · 69 (6) · 1-16
DOI: 10.3892/ijo.2026.5952 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 30.10.2026. Verfasst von Wesam H Abdulaal und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia. Hauptthemen laut MEDLINE: Neoplasms, Pyroptosis, Nanoparticles. Die Arbeit nennt 233 Literaturangaben.
Abstract (Originalsprache)
Pyroptosis is a form of programmed cell death characterized by activation of inflammasome complexes and caspase signaling cascades, ultimately leading to the cleavage and activation of pore‑forming executioners such as gasdermin D (GSDMD), ‑E and ‑B. Accumulating evidence indicates that pyroptosis induction in cancer cells exerts potent antitumor effects. As a result, recent therapeutic strategies such as cancer nanotherapy have increasingly focused on harnessing pyroptotic cell death to improve cancer treatment outcomes. This review aimed to explore recent advances in nanotechnology‑based approaches designed to induce pyroptosis in cancer cells, with an emphasis on their potential to enhance antitumor immunity and overcome treatment resistance. It explored four distinct nanoplatforms: i) Chemo‑photodynamic systems that trigger GSDME‑mediated death by generating reactive oxygen species; ii) magneto‑plasmonic nanoparticles that use GSDME activation to modulate the tumor microenvironment, turning 'cold' tumors 'hot'; iii) bioorthogonal chemical delivery tools leveraging click chemistry for site‑specific gasdermin release; and iv) nano‑CRISPR activation scaffolds designed to boost GSDME expression and work alongside cisplatin. Beyond these platforms, the present review highlights how immune cell‑derived granzymes and interferon‑γ drive vital downstream pyroptotic pathways via GSDME and GSDMB activation. Lastly, the review weighs clinical risks, such as chronic systemic inflammation and tumor‑promoting environments, providing a realistic perspective on how to safely progress these preclinical nanotherapies into selective, effective clinical immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
- Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
- Department of Pathology, College of Korean Medicine, Kyung Hee University, Hoegidong Dongdaemun‑gu, Seoul 02447, Republic of Korea.
- College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia.
- Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Alkharj 16273, Saudi Arabia.
- Department of Biochemistry, Faculty of Medicine, Umm Al‑Qura University, Mecca 24381, Saudi Arabia.
Zitieren
APA
Abdulaal, W. H., Aljarba, N. H., Kim, B., Saadeldin, I. M., Alenzi, F. Q., Abdulkhaliq, A. A., Khan, J., Borai, A., Tuomilehto, J., Lin, E., Ajoolabady, A., Al-Qahtani, A., & Ren, J. (2026). Pyroptosis in cancer nanotherapy: Molecular mechanisms and advanced nanosystems (Review). International Journal of Oncology, 69(6), 1-16. https://doi.org/10.3892/ijo.2026.5952
Vancouver
Abdulaal WH, Aljarba NH, Kim B, Saadeldin IM, Alenzi FQ, Abdulkhaliq AA, et al. Pyroptosis in cancer nanotherapy: Molecular mechanisms and advanced nanosystems (Review). International Journal of Oncology. 2026;69(6):1-16. doi:10.3892/ijo.2026.5952
BibTeX
@article{Abdulaal2026,
author = {Abdulaal, Wesam H and Aljarba, Nada H and Kim, Bonglee and Saadeldin, Islam M and Alenzi, Faris Q and Abdulkhaliq, Altaf A and Khan, Johra and Borai, Anwar and Tuomilehto, Jaakko and Lin, E and Ajoolabady, Amir and Al-Qahtani, Ahmed and Ren, Jun},
title = {Pyroptosis in cancer nanotherapy: Molecular mechanisms and advanced nanosystems (Review)},
journal = {International Journal of Oncology},
year = {2026},
volume = {69},
number = {6},
pages = {1--16},
doi = {10.3892/ijo.2026.5952}
}
EUVIMED